Consequently, the conclusion can be drawn that the low PLP2+ Tumor EPCs score group has a higher total of immune and stromal components, with a lower proportion of tumor cells, potentially correlating with better prognostic outcomes in this group. Here, PLP2 is linked to neoplasm.